In this conversation, Bipin Patel hosts Ghaith Sankari and Paula Salme Sandrak of Bayer to discuss the evolving landscape of Health AI and its differentiation from Digital Health. They explore the personalisation capabilities of AI solutions, the impact of clinical decision support tools, ethical considerations, regulatory challenges, and the future of AI in drug discovery. The discussion emphasises the importance of accessibility and equity in AI solutions while also highlighting the hidden potential of AI in healthcare.
Listen or download our podcast on the last Thursday of every month on all podcast channels.
Brought to you by electronRx
Follow us on LinkedIn
Statements made in the podcast represent -fully- the guests' personal perspectives and do not constitute or represent Bayer's official strategy, and this should be considered as an official disclaimer . The comments we made about Bayer refer to publicly available information, and our perspectives on health AI are tied to our personal expertise.
